Holly Brigance
Nurse Practitioner · Pocahontas, ARNPI 1730332511
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$836
- Novo Nordisk$783
- Amgen$681
- AbbVie$331
- Novartis$280
- Lilly USA, LLC$202
- plus $1K from 20 others
What the payments were for
- Consulting fees$1754%
- Food & beverage$3,98496%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 33 | $836 |
| Novo Nordisk | 52 | $783 |
| Amgen | 39 | $681 |
| AbbVie | 21 | $331 |
| Novartis | 22 | $280 |
| Lilly USA, LLC | 15 | $202 |
| Pfizer | 11 | $173 |
| GSK | 11 | $171 |
| Sanofi-aventis U.S. LLC | 12 | $118 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Bayer | 4 | $61 |
| Phathom Pharmaceuticals, Inc. | 6 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $34 |
| Amarin Pharma, Inc. | 2 | $34 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Astellas Pharma US Inc | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,159 in reported general payments places this provider in the 90th percentile of 697 nurse practitioner providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 17 | $10,505 |
| OzempicSemaglutide | 11 | $10,241 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $9,676 |
| JanuviaSitagliptin Phosphate | 14 | $9,154 |
| JardianceEmpagliflozin | 14 | $8,743 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $6,478 |
| Esomeprazole Magnesium | 15 | $1,746 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $1,487 |
| Atorvastatin Calcium | 79 | $1,122 |
| Prednisone | 135 | $971 |
| Pregabalin | 20 | $950 |
| Rosuvastatin Calcium | 36 | $931 |
| Pantoprazole Sodium | 65 | $723 |
| Tamsulosin Hcl | 29 | $695 |
| Ventolin HfaAlbuterol Sulfate | 12 | $694 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $783 | $10,24111 claims |
| Boehringer IngelheimJardiance | $15 | $8,74314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 697 nurse practitioner providers in Arkansas.
Other nurse practitioner in Pocahontas
- Merideth HanksRogers$157K
- Angela JonesJonesboro$90K
- Tiffany McConathyHot Springs$54K
- Brenna FitzgeraldNorth Little Rock$46K
- Iris KennedyLittle Rock$22K
- Virginia LaliberteHot Springs$21K
- Julia PonderLittle Rock$21K
- Rhonda HillJonesboro$20K
- Dakota YoungFort Smith$15K
- Olivia CoxLittle Rock$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.